White label – Pompe disease - ClinicalTrials.eu

Safety and Antitumor Activity of PF-08634404 Alone or with Enfortumab Vedotin in Adults with Locally Advanced or Metastatic Urothelial Cancer

Recruiting

1 1 1 1
Investigated Diseases:
- Transitional cell carcinoma metastatic
Investigated Drugs:
- Enfortumab Vedotin
Study of TYRA-300 in Adults with Low Grade Upper Tract Urothelial Carcinoma to Assess Efficacy and Safety

Recruiting

2 1 1
Investigated Diseases:
- Transitional cell carcinoma
Investigated Drugs:
- Tyra-300-B01
Metronidazole, Bismuth Oxide and Tetracycline Hydrochloride Fixed‑Dose Combination vs Standard First‑line Therapy for Adults with Helicobacter pylori Infection

Recruiting

3 1 1 1
Investigated Drugs:
Study of MK-1045 alone or with Tocilizumab in patients with Non‑Hodgkin Lymphoma to evaluate safety and efficacy

Recruiting

1 1 1 1
Investigated Diseases:
- Non-Hodgkin’s lymphoma
Investigated Drugs:
- Tocilizumab
Long‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study

Recruiting

2 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Ro7790121
+1
Study of GSK5764227 Safety and Efficacy in Adults with Previously Treated Advanced Unresectable or Metastatic Sarcoma

Recruiting

1 1 1
Investigated Diseases:
- Sarcoma
Investigated Drugs:
- GSK5764227
Safety and Tolerability of Tenofovir Alafenamide Dose Escalation in Healthy Adults for Epstein‑Barr Virus Infection

Recruiting

2 1 1 1
Investigated Diseases:
- Epstein-Barr virus infection
Investigated Drugs:
- Tenofovir Alafenamide
Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

Recruiting

3 1

+1
Efficacy of Tezepelumab in Treating Bronchiolitis Obliterans Syndrome in Allogeneic Stem Cell Transplant Recipients

Recruiting

2 1 1 1
Investigated Diseases:
- Bronchiolitis
Investigated Drugs:
- Tezepelumab
A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Recruiting

3 1 1 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Risankizumab
- Guselkumab
+7

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies